156 related articles for article (PubMed ID: 31715348)
1. Impact of mixed counter ion on saturation solubility of esylate salt of a weak basic drug to formulate physically stable and non-hemolytic ready to use injectable solution.
Dalwadi G; Sun Y; Wang L; Shick J; Hicks K; Lam S; Tuliani V; Patel K
Int J Pharm; 2019 Dec; 572():118829. PubMed ID: 31715348
[TBL] [Abstract][Full Text] [Related]
2. Salt Solubility and Disproportionation - Uses and Limitations of Equations for pH
Avdeef A; Sugano K
J Pharm Sci; 2022 Jan; 111(1):225-246. PubMed ID: 34863819
[TBL] [Abstract][Full Text] [Related]
3. Disproportionation of Pharmaceutical Salts: pH
Avdeef A
Mol Pharm; 2021 Jul; 18(7):2724-2743. PubMed ID: 34142831
[TBL] [Abstract][Full Text] [Related]
4. Salt disproportionation: A material science perspective.
Thakral NK; Kelly RC
Int J Pharm; 2017 Mar; 520(1-2):228-240. PubMed ID: 28163222
[TBL] [Abstract][Full Text] [Related]
5. Salt formation to improve drug solubility.
Serajuddin AT
Adv Drug Deliv Rev; 2007 Jul; 59(7):603-16. PubMed ID: 17619064
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.
Cavanagh KL; Maheshwari C; Rodríguez-Hornedo N
J Pharm Sci; 2018 Jan; 107(1):113-120. PubMed ID: 29097226
[TBL] [Abstract][Full Text] [Related]
7. Salt Stability - The Effect of pHmax on Salt to Free Base Conversion.
Hsieh YL; Merritt JM; Yu W; Taylor LS
Pharm Res; 2015 Sep; 32(9):3110-8. PubMed ID: 25874534
[TBL] [Abstract][Full Text] [Related]
8. Kinetic Barriers to Disproportionation of Salts of Weakly Basic Drugs.
Van Duong T; Diab S; Hodnett NS; Taylor LS
Mol Pharm; 2023 Aug; 20(8):3886-3894. PubMed ID: 37494545
[TBL] [Abstract][Full Text] [Related]
9. Solubility-pH profile of desipramine hydrochloride in saline phosphate buffer: Enhanced solubility due to drug-buffer aggregates.
Marković OS; Pešić MP; Shah AV; Serajuddin ATM; Verbić TŽ; Avdeef A
Eur J Pharm Sci; 2019 May; 133():264-274. PubMed ID: 30914359
[TBL] [Abstract][Full Text] [Related]
10. Enhancing Oil Solubility of BCS Class II Drug Phenytoin Through Hydrophobic Ion Pairing to Enable High Drug Load in Injectable Nanoemulsion to Prevent Precipitation at Physiological pH With a Potential to Prevent Phlebitis.
Modi D; Jonnalagadda S; Campbell GA; Dalwadi G
J Pharm Sci; 2023 Sep; 112(9):2427-2443. PubMed ID: 36958691
[TBL] [Abstract][Full Text] [Related]
11. Preformulation study of a poorly water-soluble drug, alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol: selection of the base for dosage form design.
Serajuddin AT; Sheen PC; Mufson D; Bernstein DF; Augustine MA
J Pharm Sci; 1986 May; 75(5):492-6. PubMed ID: 3735089
[TBL] [Abstract][Full Text] [Related]
12. The Selection of a Pharmaceutical Salt-The Effect of the Acidity of the Counterion on Its Solubility and Potential Biopharmaceutical Performance.
He Y; Orton E; Yang D
J Pharm Sci; 2018 Jan; 107(1):419-425. PubMed ID: 29107790
[TBL] [Abstract][Full Text] [Related]
13. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
Skrdla PJ; Zhang D
J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
[TBL] [Abstract][Full Text] [Related]
14. Estimating the maximal solubility advantage of drug salts.
Skrdla PJ
Int J Pharm; 2021 Feb; 595():120228. PubMed ID: 33484924
[TBL] [Abstract][Full Text] [Related]
15. Measurement and Accurate Interpretation of the Solubility of Pharmaceutical Salts.
He Y; Ho C; Yang D; Chen J; Orton E
J Pharm Sci; 2017 May; 106(5):1190-1196. PubMed ID: 28153596
[TBL] [Abstract][Full Text] [Related]
16. Compound selection for development - is salt formation the ultimate answer? Experiences with an extended concept of the "100mg approach".
Korn C; Balbach S
Eur J Pharm Sci; 2014 Jun; 57():257-63. PubMed ID: 24036162
[TBL] [Abstract][Full Text] [Related]
17. Solution-mediated phase transformation of salts during dissolution: investigation using haloperidol as a model drug.
Greco K; Mcnamara DP; Bogner R
J Pharm Sci; 2011 Jul; 100(7):2755-68. PubMed ID: 21328581
[TBL] [Abstract][Full Text] [Related]
18. Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug.
Anderson BD; Conradi RA
J Pharm Sci; 1985 Aug; 74(8):815-20. PubMed ID: 4032262
[TBL] [Abstract][Full Text] [Related]
19. Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations.
Avdeef A
Eur J Pharm Sci; 2017 Dec; 110():2-18. PubMed ID: 28392495
[TBL] [Abstract][Full Text] [Related]
20. Salt stability--effect of particle size, relative humidity, temperature and composition on salt to free base conversion.
Hsieh YL; Taylor LS
Pharm Res; 2015 Feb; 32(2):549-61. PubMed ID: 25145335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
